The cowpox virus-encoded anti-apoptotic protein cytokine response modifier A (CrmA) is a member of the serpin family that specifically inhibits the cellular proteins caspase 1, caspase 8 and granzyme B. In this study, we have used Flag-and yellow fluorescent protein (YFP)-tagged versions of CrmA to investigate the mechanisms that regulate its subcellular localization. We show that CrmA can actively enter and exit the nucleus and we demonstrate the role of the nuclear export receptor CRM1 in this shuttling process. CrmA contains a novel leucine-rich nuclear export signal (NES) that is functionally conserved in the antiapoptotic cellular serpin PI-9. Besides this leucine-rich export signal, additional sequences mapping to a 103-amino-acid region flanking the NES contribute to the CRM1-dependent nuclear export of CrmA. Although YFP-tagged CrmA is primarily located in the cytoplasm, shifting its localization to be predominantly nuclear by fusion of a heterologous nuclear localization signal did not impair its ability to prevent Fas-induced apoptosis. We propose that nucleocytoplasmic shuttling would allow CrmA to efficiently target cellular pro-apoptotic proteins not only in the cytoplasm, but also in the nucleus, and thus to carry out its antiapoptotic function in both compartments.
INTRODUCTION
The regulated self-destruction of a cell by apoptosis constitutes a complex process that involves the co-ordinated activity of proteins localized to different subcellular compartments, such as the cell membrane, cytoplasm, mitochondria and nucleus. The apoptotic pathway triggered by the interaction between the death receptor Fas (CD95/APO-1) and its ligand on the cell membrane clearly illustrates this complexity (reviewed in [1] ). Ligand binding leads to oligomerization of Fas and recruitment of cytoplasmic pro-caspase 8 to the intracellular domain of the receptor. Recruitment to the receptor, mediated by the adaptor protein FADD (Fas-associated death domain), results in the selfprocessing and activation of caspase 8 which, in turn, initiates a cascade of caspase-mediated proteolytic events that eventually leads to DNA fragmentation and degradation of nuclear proteins. Because activation of the caspase cascade in the cytoplasm ultimately leads to a series of nuclear changes that constitute classical hallmarks of apoptosis, the relay of the apoptotic signal to the nucleus is thought to represent an important step in the apoptotic process [2] .
Communication between the nucleus and cytoplasm takes place through the nuclear pore complexes, gated channels that penetrate the double membrane of the nuclear envelope [3] . The diameter of these channels allows free diffusion of small molecules, but translocation of many proteins across the nuclear envelope involves active transport mechanisms mediated by specific import or export receptors [4] . Selective transport in and out of the nucleus depends on the presence of nuclear localization signals (NLSs) or nuclear export signals (NESs) in the cargo protein, that are recognized by the import and export receptors respectively [5, 6] . How the nucleocytoplasmic transport machinery is involved in conveying the apoptotic signal to the nucleus remains to be clearly established. Elucidating the mechanisms and identifying Abbreviations: CHX, cycloheximide; CrmA, cytokine response modifier A; GFP, green fluorescent protein; LMB, leptomycin B; NES, nuclear export signal; NLS, nuclear localization signal; PARP, poly(ADP-ribose) polymerase; SV40, simian virus 40; YFP, yellow fluorescent protein. 1 To whom correspondence should be addressed (e-mail ja.rodriguez@vumc.nl).
the signals that regulate the nucleocytoplasmic localization of the proteins that are involved in the execution or regulation of apoptosis may contribute to our understanding of this process. Several viruses have evolved proteins that interfere with the cellular apoptotic machinery as a mechanism to counteract the host immune response to infection. One of the best-characterized viral anti-apoptotic proteins is the cowpox virus-encoded CrmA (cytokine response modifier A), a 38 kDa protein member of the serine protease inhibitor (serpin) superfamily [7] . CrmA plays a critical role in viral pathogenesis by inactivating three cellular proteases: caspase 1, caspase 8 and granzyme B [7] [8] [9] [10] [11] . By targeting caspase 8 and granzyme B, CrmA blocks cytotoxic T lymphocyte-induced suicide of infected cells mediated by the Fas or the perforin/granzyme apoptotic pathways [9] [10] [11] . On the other hand, inhibition of caspase 1 prevents the proteolytic activation of pro-interleukin-1β [7, 8] , compromising the host inflammatory response. Besides its physiological role, CrmA is widely used as a tool to determine the role of particular pathways in the cellular response to different pro-apoptotic stimuli due to its target specificity [12] [13] [14] .
The subcellular localization of the three cellular proteases targeted by CrmA has been addressed in several reports [15] [16] [17] [18] [19] [20] [21] . They have been shown to enter the nucleus during apoptosis [15] [16] [17] 21] , and a classical NLS has been identified in the prodomain of caspase 1 [18] . CrmA has been shown previously to localize to either the cytoplasm [7] or both to the nucleus and cytoplasm [22] , but the transport mechanisms and signals that regulate its subcellular localization have not been defined. The current view is that its small size allows CrmA to freely diffuse through the nuclear pores into the nucleus [22] . We show here that, besides passive diffusion, active cellular mechanisms of nucleocytoplasmic transport, including CRM1-dependent nuclear export, determine the subcellular localization of CrmA. We have identified and characterized in detail a novel leucine-rich NES in
CrmA that is functionally conserved in the cellular anti-apoptotic serpin PI-9. Interestingly, CRM1-dependent nuclear export of CrmA is mediated not only by its leucine-rich export signal, but also by additional sequences that we mapped to a 103-amino-acid segment flanking the NES. The ability of CrmA to shuttle between the two cellular compartments suggests that it may function as an anti-apoptotic protein not only in the cytoplasm, but also in the nucleus. In support of this possibility, we show that the ability of yellow fluorescent protein (YFP)-CrmA, a primarily cytoplasmic protein, to prevent Fas-induced apoptosis is fully preserved when its localization is artificially shifted to be predominantly nuclear by the fusion of a heterologous NLS.
MATERIALS AND METHODS

Cell culture, transfection and leptomycin B (LMB) treatment
Human tumour-derived cell lines MCF-7 (breast carcinoma), HeLa (cervical carcinoma), A431 (vulval carcinoma), SW1573 (lung carcinoma) and HepG2 (hepatic carcinoma) were grown in RPMI or Dulbecco's modified Eagle's medium (BioWhittaker), supplemented with 10 % (v/v) fetal calf serum, 100 units/ml penicillin and 100 µg/ml streptomycin (Gibco BRL). Cells were seeded on to sterile glass coverslips in 6-or 12-well trays, and transfected with 0.5-2 µg of plasmid DNA using the FuGene6 transfection reagent (Roche Molecular Biochemicals), following the manufacturer's protocol. LMB (generously provided by Dr Minoru Yoshida, University of Tokyo, Tokyo, Japan) was added to the culture medium to a final concentration of 6 ng/ml and the cells were incubated at 37
• C for the indicated period of time.
Cloning procedures and plasmid construction
The mammalian expression vectors pEF-FlagpGKpuro-CrmAwt and pEF-FlagpGKpuro-CrmAmt, encoding Flag-tagged wildtype CrmA or an inactive point mutant (Thr 291 → Arg) variant respectively [14] , were generously provided by Dr David L. Vaux (The Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia). To generate the plasmid encoding FlagCrmA + NLS, the NLS of the simian virus 40 (SV40) large T antigen (PKKKRKV) [23] was cloned at the C-terminal end of wild-type CrmA using PCR with primers JAR34 and JAR61 (Table 1) . The PCR product, digested with NdeI and XbaI restriction enzymes (Roche Molecular Biochemicals), was used to replace an NdeI/XbaI-excised fragment at the 3 -end of CrmA cDNA. To create the YFP-tagged versions of CrmA, CrmAT291R and CrmA + NLS, the corresponding cDNAs were amplified by PCR using primer set JAR51/JAR56 (CrmA wt and T291R) or JAR51/JAR83 (CrmA + NLS) and cloned as HindIII/KpnI fragments into the pEYFP-C1 expression plasmid (Clontech, Palo Alto, CA, U.S.A.). PCR was also used to generate the deletion mutants of CrmA fused to YFP. The primer sets used to amplify each CrmA fragment were JAR51/JAR52 (residues 1-149), JAR53/JAR56 (100-341), JAR55/JAR56 (200-341), JAR53/ JAR54 (100-270), JAR100/JAR102 (150-200), JAR55/JAR54 (200-270) and JAR101/JAR72 (263-303).
The DNA segments encoding the NES-like sequences of CrmA and a short flanking region were amplified by PCR using CrmA cDNA as template and cloned as BamHI/AgeI fragments into the previously described Rev(1.4)-GFP plasmid [24] (where GFP is green fluorescent protein). This plasmid, as well as the positive control for the export assay containing the wild-type Rev NES, were kindly provided by Dr Beric R. Henderson (The Westmead Institute for Cancer Research, Sydney, Australia). The primer sets . Similarly, the DNA segments encoding the amino acid sequences of α1-antitrypsin, PI-9, and Maspin similar to CrmA NES were amplified by PCR using genomic or cDNA from Jurkat cells as template, and cloned as BamHI/AgeI fragments into Rev(1.4)-GFP. The primer sets used in this case were JAR75/JAR76 (α1-antitrypsin), JAR77/JAR78 (PI-9) and JAR79/JAR80 (Maspin). The single amino acid substitutions of CrmA NES in the export assay construct were generated using mutagenic PCR primers JAR24 (Leu 255 → Ala) and JAR25 (Leu 253 → Ala) in combination with JAR10. In all cases, the high fidelity DNA polymerase Pfu (Stratagene, La Jolla, CA, U.S.A.) was used in the PCR reactions, and the sequence of the inserts was verified by DNA sequencing.
Site-directed mutagenesis of CrmA NES
A two-step PCR-based site-directed mutagenesis approach was used to generate the NES-defective CrmA NES , introducing two point mutations (Leu 253 → Ala and Leu 255 → Ala) in the NES of CrmA. Two overlapping PCR fragments were amplified with primer combinations JAR34/JAR33 and JAR32/JAR35. Following gel-purification, the PCR products were mixed, annealed, and used as template for a second round of amplification with primers JAR34 and JAR35. The product of this second reaction was digested with NdeI and XbaI and used to replace the NdeI/XbaI-excised 3 -end of CrmA. After confirming the presence of the mutation by DNA sequencing, this plasmid was used as template in PCR reactions to generate YFP-CrmA NESm (primer set JAR51/JAR56), and the different YFP-fusion fragments of CrmA containing the NES mutation: 100-341
NESm (primer set JAR53/JAR56), 200-341
NESm (primer set JAR55/JAR56), 200-303
NESm (primer set JAR 55/JAR72), and 200-270 NESm (primer set JAR55/JAR54). In all cases, the PCR products were inserted as HindIII/KpnI fragments into pEYFP-C1.
Immunocytochemistry, fluorescence microscopy analysis and quantification of subcellular distribution
Cells transfected with plasmids encoding YFP-tagged proteins were fixed with 3.7 % formaldehyde in PBS for 30 min at room temperature, stained with the chromosome dye Hoechst 33285 (Sigma) for 30 min to counterstain the nuclei, and mounted on to microscope slides using Vectashield (Vector). Immunocytochemical detection of Flag-tagged CrmA was performed with the anti-Flag M2 monoclonal antibody (Stratagene), and a fluorescein isothiocyanate-conjugated goat anti-mouse secondary antibody (Santa Cruz), using a previously described immunostaining method [25] . Fluorescence microscopy analysis was carried out using an inverted Leica DMIRB/E fluorescence microscope (Leica Heidelberg, Heidelberg, Germany). Images were collected using the Q500MC Quantimet software V01.01 (Leica Cambridge, Cambridge, U.K.). To quantitatively determine their subcellular distribution, the localization of the ectopically expressed proteins was assessed in at least 200 transfected cells per sample. The degree of LMB-induced nuclear accumulation of proteins (LMB effect) was calculated as described previously [25] .
In vivo Rev(1.4)-GFP nuclear export assay
The NES-like motifs in CrmA and other serpins were tested for export activity using the Rev(1.4)-GFP in vivo nuclear export assay [24] . Duplicate samples of MCF-7 cells were transfected with pRev(1.4)-GFP (negative control) and its derivative plasmids containing each of the candidate export sequences or the wild-type Rev NES (as positive control). At 24 h post-transfection, cells were treated for 3 h with either 10 µg/ml cycloheximide (CHX) plus 5 µg/ml actinomycin D or with CHX alone. CHX treatment ensures that cytoplasmic GFP arises from nuclear export and not from new protein synthesis, whereas actinomycin D prevents, by an undefined mechanism, the nuclear import of Rev and thus allows detection of weaker NESs. The subcellular localization of the GFP-fusion proteins was determined in at least 200 cells per sample and the activity of the functional NESs was rated according to the published scoring system [24] . The CRM1-dependence of the functional NESs identified in the nuclear export assay was further confirmed by LMB treatment of the transfected cells (6 ng/ml for 3 h).
Sequence alignment analysis
The amino acid sequence comparison between CrmA and cellular serpins was carried out using the BLASTP 2.2.3 program available at the National Center for Biotechnology Information website (www.ncbi.nlm.nih.gov).
Induction and evaluation of Fas-dependent apoptosis
Duplicate samples of HeLa cells were transfected with expression plasmids encoding three YFP-tagged variants of CrmA: the wild-type protein, CrmA + NLS and, as control, the previously described loss-of-function mutant T291R [14] . At 24 h posttransfection, cells were treated with 100 ng/ml anti-Fas activating human monoclonal antibody CH11 (Upstate Biotechnology) plus 2 µg/ml CHX. After 20 h of incubation under control conditions or in the presence of anti-Fas/CHX, cells were examined using an inverted Leica DMIRB/E fluorescence microscope under UV and visible light. Viable cells were scored as those that remained attached to the plate and did not show morphological signs of apoptosis. The percentage of viability of transfected cells was determined by examining at least five independent microscopy fields and counting more than 600 YFP-positive cells. As a marker for apoptotic cell death, the cleavage of poly(ADP-ribose) polymerase (PARP) was determined, as previously described [26] , in protein extracts generated from the detached and attached cell sub-populations of samples transfected with YFP-CrmA and YFP-CrmA + NLS. We also used an anti-GFP antibody (Sigma) to determine the expression of YFP-CrmA and YFP-CrmA + NLS in these cell sub-populations, and anti-actin antibody (Sigma) to control for equal protein loading.
RESULTS
The nucleocytoplasmic localization of CrmA is regulated by cellular mechanisms of active transport, including CRM1-dependent nuclear export
To investigate its subcellular localization, we transfected HeLa human cervical carcinoma cells with expression vectors encoding CrmA tagged with either a Flag epitope (Flag-CrmA) or YFP (YFP-CrmA). Fluorescence microscopy analysis ( Figure 1A ) of CrmA-expressing cells revealed a complex pattern of nucleocytoplasmic distribution, with CrmA being present only in the cytoplasm of some cells, but localizing to either the nucleus or both the nucleus and cytoplasm of other cells. The subcellular distribution of CrmA was influenced by the size of the tag used: the 65 kDa non-diffusing YFP-CrmA fusion protein was more often excluded from the nucleus than the smaller Flag-CrmA. We extended the analysis of YFP-CrmA localization to a broader panel of human cells derived from different types of tumour (Table 2) . In every cell line tested, approx. 20-30 % of the transfected cells showed at least partial nuclear accumulation of YFP-CrmA. This indicates that nuclear import of CrmA occurs, at least in part, by an active mechanism.
These observations, and a recent report that the localization of the cellular serpin PI-9 is regulated by the export receptor CRM1 [22] , prompted us to investigate the possibility that CrmA undergoes CRM1-dependent nuclear export. Treatment of the cells with the specific CRM1 inhibitor LMB [27] resulted in a consistent relocation of CrmA to the nucleus of MCF-7 and HeLa cells ( Figure 1B) , indicating a role for CRM1 as a mediator of CrmA nuclear export. The limited LMB effect observed could be due either to a slow rate of nuclear import or to the selective retention of CrmA in the cytoplasm caused by interaction with other proteins. Fusion of the NLS of the SV40 large T antigen [23] to the C-terminus of CrmA readily induced the nuclear accumulation of CrmA (see below and Figure 6A ), indicating that a slow rate of nuclear import is largely responsible for the limited nuclear accumulation of CrmA upon LMB treatment, whereas cytoplasmic retention plays only a minor role. Altogether, these findings indicate that, in addition to the previously described diffusion through the nuclear pore, a slow rate of active nuclear import and CRM1-dependent nuclear export are major determinants of the subcellular localization of CrmA.
CrmA contains a functional leucine-rich NES
To map the regions involved in regulating CrmA nucleocytoplasmic transport, we generated a series of deletion mutants of CrmA fused to YFP. These constructs were transfected into MCF-7 cells and the subcellular distribution, as well as the response to LMB treatment of each region, was determined. As shown in Figure 2 , the localization of CrmA fragments encompassing amino acids 1-149 and 150-200 did not change following incubation with LMB for 3 h. In contrast, LMB treatment induced a dramatic relocation of the other four CrmA fragments to the nucleus, which was already evident at 30 min after addition of the drug (results not shown). The results of this analysis clearly indicated the presence of sequences mediating CRM1-dependent nuclear export in the segment encompassing CrmA amino acids 200-270. In addition, the intense and rapid nuclear accumulation of the deletion mutant YFP-CrmA-(100-341) upon LMB treatment provides further evidence that CrmA is actively imported into the nucleus and, importantly, shows that sequences in the N-terminal region of CrmA may negatively regulate this process. Visual examination of the amino acid sequence of CrmA segment 200-270 revealed the presence of three motifs that resemble the NES of HIV Rev protein ( Figure 3A) . These motifs consist of a cluster of large hydrophobic amino acids with a characteristic spacing. To determine if these NES-like motifs function as CRM1-dependent export signals, we used a recently developed in vivo nuclear export assay [24] . In this assay, the ability of a potential NES to complement the inactivated NES of the Rev(1.4) mutant protein is assessed. The export-deficient fluorescent protein Rev(1.4)-GFP is trapped in the nucleus, and active NESs are identified by their ability to induce its relocation to the cytoplasm when inserted between the Rev(1.4) and the GFP moieties. The extent of this relocation reflects the strength of the NES tested and thus the activity of different NESs can be compared and classified according to the proportion of cells with cytoplasmic GFP.
Two short fragments of CrmA encompassing the NES-like motifs and a few flanking residues were cloned into Rev(1. . In contrast, CrmA fragment 223-244 showed no export activity in this assay. The subcellular distribution of each protein is indicated in the insets: N, nuclear; NC, nuclear and cytoplasmic; C, cytoplasmic. Results are the mean of two independent experiments with less than 10 % variation. More than 200 cells per sample were counted in each experiment. According to the scoring system used in this assay [24] , the activity of CrmA NES was classified as 9+, the same as that of Rev NES (positive control). Act.D, actinomycin D. (C) LMB treatment (6 ng/ml for 3 h) or mutagenesis of leucine residues Leu 253 or Leu 255 to alanine (Leu253Ala and Leu 255Ala respectively) abrogates CrmA NES-mediated nuclear export.
The overlapping NES-like motifs I and II were tested using a single fragment (223-244). As shown in Figure 3(B) , only the CrmA fragment 242-259, which includes NES-like motif III, was able to induce the relocation of Rev(1.4)-GFP to the cytoplasm, indicating that this motif constitutes a functional, transferable NES. Under the conditions of this assay, the CrmA NES was as active as the Rev NES, resulting in > 80 % cytoplasmic localization of GFP, even in the presence of active Rev-mediated import (untreated samples in Figure 3B ). The export activity of CrmA NES was therefore classified as 9+, the highest score in the NES scoring system used with this export assay [24] . Incubation with LMB or with mutants containing leucineto-alanine substitutions of two of the residues that conform to the consensus NES sequence (Leu 253 and Leu 255 ) ( Figure 3C ) efficiently abrogated CrmA NES-induced relocation of Rev(1.4)-GFP to the cytoplasm. These results therefore confirmed that the CrmA NES mediates nuclear export via the CRM1-dependent pathway, and identified critical residues for its activity.
The NES is functionally conserved in the cellular anti-apoptotic serpin PI- 9 An amino acid sequence comparison between CrmA and a number of cellular serpins revealed that the four leucine residues that conform to the consensus NES motif are commonly conserved or changed to another hydrophobic residue such as methionine or isoleucine ( Figure 4A ). Thus the functionality of the signal might a priori be preserved, as such residues are often found in functional export signals, such as the NESs of PKI (protein kinase inhibitor) [28] or Ran-BP1 [29] . On the other hand, the neighbouring residues may also affect the activity of an NES [24] and therefore the functional status of this sequence in the different serpins cannot be directly inferred from sequence similarity. Using the nuclear export assay, we tested the region of identity with CrmA NES corresponding to the cellular serpins PI-9, α1-antitrypsin and Maspin. Of the three sequences tested, which show a variable degree of similarity to CrmA NES, only the PI-9 motif was found to be a functional NES ( Figure 4B ). The export activity of PI-9 NES was classified as 2+, considerably weaker than CrmA NES in this assay.
Additional sequences flanking the NES contribute to CrmA nuclear export
To analyse the activity of the NES in the context of the full-length protein, we used site-directed mutagenesis to generate a NESdefective CrmA variant (CrmA NESm ) containing two leucine-toalanine point mutations that abrogate the activity of the NES in the nuclear export assay (Leu 253 → Ala and Leu 255 → Ala, Figure 5A ). Although the localization of Flag-CrmA NESm in HeLa cells was less cytoplasmic than that of the wild-type protein, the mutational inactivation of the NES did not fully account for the LMB response ( Figure 5B, upper panel) . Similar results were observed for YFP-CrmA NESm (results not shown). Since the CrmA N-terminal region negatively regulates its nuclear import (see Figure 2) , we introduced the NES-inactivating substitutions into the CrmA deletion mutant lacking the first 100 amino acids. Inactivation of the NES had a more dramatic effect in the context of CrmA-(100-341) ( Figure 5B, lower panel) . The proportion of cells showing nuclear localization of this protein increased markedly and its cytoplasmic localization was almost completely abrogated. However, as observed for its full-length counterpart, inactivation of the NES did not fully account for the LMB response, and the nuclear relocation of CrmA-(100-341) NESm was further enhanced by treatment with LMB. Surprisingly, CrmA
NESm was more cytoplasmic than the wild-type protein in MCF-7 cells (results not shown), and its nuclear accumulation in reponse to LMB cells was decreased, suggesting that the Leu 253 → Ala and Leu 255 → Ala mutations may interfere with the nuclear import of CrmA in MCF-7 cells. These results therefore clearly indicate that the NES is only partially responsible for CrmA nuclear export in HeLa cells. According to the deletion analysis shown in Figure 2 , other sequence motifs that might contribute to CRM1-dependent nuclear export of CrmA should be located within the CrmA region 200-341. To more precisely map these elements, we first tested two NES-like sequences located in this region (S 195 MVVI LPDNIDGLESIEQNL and 316 HPFIYVIRHVDGKILFVGRYC; one-letter amino acid symbols, with bold letters highlighting residues of interest). Both sequences were negative in the nuclear export assay (results not shown). Next, we introduced the NES-inactivating mutations into YFP-tagged CrmA fragments spanning the 200-341 segment ( Figure 5C NESm . However, further N-or Cterminal deletions abrogated the response to LMB. Combined, the results of this analysis enabled us to map the sequences responsible for NES-independent nuclear export of CrmA to an amino acid segment flanking the NES, comprising residues 200-303. Importantly, this region does not appear to contain other functional leucine-rich export signals.
Enhanced nuclear localization does not alter the ability of CrmA to prevent Fas-induced apoptosis
The ability of CrmA to undergo active nucleocytoplasmic transport suggests that it might carry out its anti-apoptotic function not only in the cytoplasm, but also in the nucleus. To optimally address this possibility, the anti-apoptotic activity of CrmA when exclusively located to the nucleus should be tested. This was hampered by the slow rate of nuclear import of CrmA and the fact that inactivating the NES does not fully prevent its nuclear export. One would expect, however, that enhancing the accumulation of CrmA in the nucleus would decrease its activity, if nuclear CrmA were unable to prevent apoptosis. Therefore we fused the strong NLS of the SV40 large T antigen to the C-terminal end of CrmA to generate a chimaeric protein (CrmA + NLS), the ability of CrmA to protect HeLa cells from Fas-induced apoptosis.
DISCUSSION
It has recently become apparent that several members of the serpin family localize, to a different extent, to the cell nucleus [22, [30] [31] [32] . Although it is predominantly localized in the cytoplasm, the viral anti-apoptotic serpin CrmA has been proposed to enter the nucleus by diffusion through the nuclear pores [22] . Our results, comparing the localization of Flag-and YFP-tagged forms of CrmA, indicate that, in addition to passive diffusion, active transport mechanisms can regulate the nucleocytoplasmic localization of CrmA. The role of passive diffusion is evident from the different subcellular distribution of Flagand YFP-tagged CrmA. As expected, the smaller Flag-CrmA was more frequently detected in the nucleus. The involvement of active nuclear import was first suggested by our observation that YFP-CrmA partially accumulates in the nucleus of human cells of different origin. YFP-CrmA is a 65 kDa protein whose size would prevent passive diffusion through the nuclear pores, thus requiring an active import process to enter the nucleus. Our findings contrast with the reported inability of GFP-CrmA to enter the nucleus of COS-1 cells [22] , raising the possibility that cell-type-specific factors may affect active nuclear import of CrmA.
CrmA does not contain a classical NLS, such as the short stretch of basic amino-acids (Lys 74 -Lys-Arg-Lys) that mediates nuclear import of the cellular serpin PI-10 [30] . However, other cellular members of the serpin family, such as PI-9, have been shown to enter the nucleus using a non-conventional mechanism of active import that does not rely on the presence of such sequences [22] . We show here that, like PI-9, CrmA is able to undergo CRM1-mediated nuclear shuttling and it is possible that both serpins also share similar import mechanisms. Blocking CRM1-dependent nuclear export with LMB induced only a partial relocation of CrmA to the nucleus, comparable with the LMB effect we have previously observed on another shuttling protein, BRCA1 [25] , but smaller than the effect on HIV Rev [25] or survivin [33] . Thus in comparison with that of PI-9, nuclear import of CrmA seems to be a slow process. Interestingly, a CrmA deletion mutant lacking the N-terminal 100 residues rapidly accumulates into the nucleus upon LMB treatment, suggesting that the CrmA N-terminal region may negatively regulate its nuclear import.
We have identified a motif in CrmA (G 242 SYNLVDALVK-LGLTEVF; one-letter amino acid symbols, with bold letters highlighting residues of interest) that constitutes an autonomous, transferable leucine-rich NES. The activity of this novel NES is comparable with that of HIV Rev export signal when tested using an in vivo nuclear export assay [24] . Furthermore, we show that the PI-9 sequence (E 276 DYDMESVLRHLGIVDAF), homologous with CrmA NES, is also a functional, although weaker, NES. No other export signals have been identified in this cellular serpin, and the role of the NES reported here in the context of full-length PI-9 remains to be established. Nevertheless, by comparison with CrmA NES, we would predict that mutation of hydrophobic residues conforming to the NES consensus sequence, such as Leu 287 and Ile 289 , would decrease PI-9 nuclear export. Despite its strong activity in the nuclear export assay, the NES appears to play only a partial role in CrmA nuclear export in HeLa cells, a process that seems to be largely mediated by additional sequences in the amino acid segment 200-303, flanking the NES. This region does not contain other active leucine-rich export signals but might represent a binding site for another NES-containing protein, which may bridge the interaction with CRM1. It is possible that the contribution of the NES to CrmA export changes under different conditions. One must consider, in this regard, that a prominent characteristic of serpins is their conformational instability [34] . This property allows serpins to adopt different conformations and may conceivably lead to exposure or masking of different motifs, including the NES, under different conditions. In this regard, we noted that mutational inactivation of the NES had a dramatic effect in the context of CrmA-(100-341). This observation suggests that deletion of the N-terminal end leads not only to increased nuclear import of CrmA, but also to exposure of the NES. More puzzling is the observation that NES-inactivating mutations appear to reduce nuclear import of CrmA in MCF-7 cells. The mechanism underlying this effect remains to be established, but the different consequences of the NES mutation in HeLa and MCF-7 cells constitute a clear example that the cellular context may influence the dynamics of CrmA nucleocytoplasmic transport.
The nuclear shuttling ability of CrmA raises the possibility that it may carry out its anti-apoptotic function in the cytoplasm and the nucleus. Testing this possibility was hampered by the fact that the NES is not the only motif mediating CrmA export. It was therefore not possible to completely abrogate this process without deleting a large amino acid segment. This gross deletion would presumably alter CrmA structure and function, preventing a meaningful comparison with wild-type CrmA. As an alternative approach to gain some insight into the functionality of CrmA in the nucleus, we generated a chimaeric protein, fusing the NLS of SV40 large T antigen to the C-terminal end of CrmA. Although CrmA + NLS still has the potential to undergo nuclear export, the strong NLS results in its rapid re-import into the nucleus. Thus whereas YFP-CrmA is predominantly cytoplasmic, YFPCrmA + NLS accumulates strongly into the nucleus. Consistent with the view that CrmA may have an anti-apoptotic activity in the nucleus, we found that the ability of YFP-CrmA + NLS to prevent Fas-induced apoptosis is fully preserved.
In summary, our results reveal that the subcellular localization of CrmA is regulated in a more complex way than previously suspected. Its ability to shuttle between nucleus and cytoplasm may enable CrmA to efficiently target the pro-apoptotic proteins caspase 1, caspase 8 and granzyme B for inactivation in either cellular compartment. The two novel leucine-rich NESs reported here are, to our knowledge, the first NESs to be identified in the serpin family.
